Pharma Bio Serv Inc (OTCMKTS:PBSV) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.79 and traded as low as $0.72. Pharma Bio Serv shares last traded at $0.73, with a volume of 1,134 shares trading hands.
Separately, ValuEngine lowered Pharma Bio Serv from a “sell” rating to a “strong sell” rating in a research note on Friday, November 1st.
The stock has a market capitalization of $17.09 million, a P/E ratio of -14.60 and a beta of 0.19. The company has a 50 day simple moving average of $0.79 and a 200-day simple moving average of $0.90.
Pharma Bio Serv (OTCMKTS:PBSV) last issued its earnings results on Monday, September 16th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.02. The firm had revenue of $4.97 million for the quarter, compared to analyst estimates of $4.42 million. Pharma Bio Serv had a return on equity of 10.02% and a net margin of 24.28%. As a group, equities research analysts anticipate that Pharma Bio Serv Inc will post 0.09 earnings per share for the current year.
Pharma Bio Serv Company Profile (OTCMKTS:PBSV)
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil.
Further Reading: Consumer behavior in bull markets
Receive News & Ratings for Pharma Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.